News | March 14, 2023
Pfizer acquires Seagen for US$ 43 billion to battle cancer
Proposed combination enhances Pfizer’s position as a leading company in oncology
Proposed combination enhances Pfizer’s position as a leading company in oncology
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Subscribe To Our Newsletter & Stay Updated
